¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ Ip=QtNW3 \  
EG$-D@o\I  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© g1"Z pD  
un -h%-e |  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© u a_w5o7  
b7I0R; Zj  
1.Co-stimulators (or co-stimulating molecules) |9IOZ>H9  
3oH/34jj  
2.NK-kB X;GU#8W  
alHA&YC{K  
3.Immunoglobulin superfamily ty rP[y  
/V/NL#(R  
4.antigen-presenting cell (APC) ~LV]cX2J(  
Q1x&Zm1v  
5.death domain <bSPKTKL  
'ROz|iJ  
6.CCR and CXCR REK):(i7P  
%X %zK1  
7.Lectin (or mitogen) =RRv& "2r  
U.P1KRY|=  
8.Clusters of differentiation, CD) #G F.M,O/h  
k_wcol,W  
9.B7 family ZCc2 3UwI  
F!)[H["_  
10.Cytotoxic T lymphocyte, CTL) J9*;Bqzim  
NQ 6oyg@&  
11.IL-15 and IL-15 receptor (IL-15R) :}Yk0*  
5 D^#6h 4  
12.MHC restriction Z.Z;p/4F  
 'F. P93  
13.Affinity-chromatography !8[A;+o3P  
O)VcW/  
14.Cyctosprin A, CsA K&NH?  
Er~KX3vF  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 2v4K3O60G  
!s1<)%Jt  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© q/I( e  
s a o&  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 2 >O[Y1  
]j/= x2p  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ L k nK  
t}h(j|  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ Q2m[XcnX  
~//9Nz~;3  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© N^[ F+y  
:K2 X~Ty  
ÃâÒßѧרҵ£º K a(B&.  
P`Ku . ONQ  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ !vu -`u~86  
Oz-/0;1n  
Ïû»¯ÄÚ¿Æ£º  8el6z2  
>KrI}>!9r  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 1K@ieVc  
e7xv~C>g  
ѪҺ²¡Ñ§×¨Òµ£º /fT"WaTEK  
|Ol29C$@|  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»